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Abstract
Background: Research into musculoskeletal conditions often focusses on pain at single sites, such as the knee, yet
several studies have previously reported the high prevalence of multiple sites of musculoskeletal pain. The most
common form of musculoskeletal condition is arthritis, with osteoarthritis (OA) the most common cause of joint
pain in adults 45 years and over. However, there is limited recognition of the prevalence of multisite peripheral
joint pain in those either living with or at risk of OA, therefore this study set out to estimate the prevalence of
multisite peripheral joint pain in adults 45 years and older, and its impact on several dimensions of health.
Methods: A cross-sectional population survey was mailed to adults (n = 28,443) aged 45 years and over from eight
general practices in the North West Midlands, United Kingdom (UK). Prevalence rates were established for multisite
peripheral joint pain (pain in two or more sites; hands, hips, knees, feet). Impact was measured for general health
(SF-12 MCS & PCS), QoL (EQ-5D), pain intensity (0-10 numerical ratings scale) and the number of consultations with
a range of health care professionals.
Results: Of 15,083 responders (53%), multisite peripheral joint pain was reported by 54%. Peripheral joint pain was
present in n = 11,928, of which 68% reported pain in multiple sites. Multisite peripheral joint pain was shown to be
significantly associated with reduced physical (Mean difference = −5.9 95% CI -6.3,-5.5) and mental (−2.8 95% CI -3.
2,-2.4) components of the SF-12, reduced QoL (−0.14 95% CI -0.15, −0.13), increased pain (+0.70 95% CI 0.62, 0.79)
and increased odds of consultations with GPs (OR 2.4 95% CI 2.2, 2.6) and practice nurses (OR 2.6 (95% CI 2.1, 3.2)
when compared to single site pain.
Conclusions: Multisite peripheral joint pain is prevalent in the population in adults 45 years and over and has a
significant negative impact on several dimensions of health. Health care professionals should consider joint pain
beyond the index site in order to address holistic management.
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Background
Two out of three people over the age of 50 years report
musculoskeletal pain [1] and it is a common reason for
consulting in general practice [2]. The most common
form of musculoskeletal disease is arthritis, with osteo-
arthritis (OA) the most common cause of peripheral
joint pain in adults 45 years and over [3]. Research into
peripheral joint pain often focusses on pain at single
sites, such as the knee or the hip, yet several studies
have previously reported the high prevalence of multisite
peripheral joint pain in the person [4–7]. There is lim-
ited recognition of the prevalence of multisite peripheral
joint pain in those either living with or at risk of OA.
Clinical guidelines for OA in the UK provide recom-
mendations for the hands, hips, knees and feet and sug-
gest that many people with OA will have it in multiple
sites [8]. The purpose of this study was to determine the
prevalence and impact of multisite peripheral joint pain
(pain in two or more sites from the hands, hips, knees
or feet) in a community dwelling population aged
45 years and over.
Methods
Design and participants
A cross-sectional population survey formed part of the
‘Managing Osteoarthritis in Consultations’ MOSAICS
study [9]. The postal survey was mailed to 28,443 adults
aged 45 years and over registered in eight general prac-
tices in the North West Midlands, UK. Prior to mailing,
general practitioners (GPs) had the opportunity to
screen their lists and exclude ineligible participants e.g.
having a psychiatric illness, experienced a recent family
bereavement etc. Individuals contacting the research
team and not wishing to take part in the survey were
tagged in the practices as exclusions and were not con-
tacted again for the study. The population survey used a
two-stage mailing process, where eligible participants
were sent a letter of invitation to take part in the study
and given information about the study. The study was
approved by the North West Midlands 1 Research Ethics
Committee, Cheshire, UK, as part of the MOSAICS study
(ISRCTN number: ISRCTN06984617) [9]. The findings
are reported in line with the STROBE guidelines [10].
Data collection
The survey collected demographic information (age, gen-
der, height, weight) and individual deprivation scores were
derived from postal codes (Table 1). Survey questions
asked if participants had experienced any pain in or
around the hands, hips, knees or feet in the past
12 months, and if yes, to give an average pain intensity
score (0-10 numerical ratings scale) for each painful per-
ipheral joint site. General health was measured using the
SF-12 physical component scale (PCS) and mental
component scale (MCS) [11]. Quality of life (QoL) was
measured using the EQ-5D (3-level) [12] and consultation
behaviour was measured through asking participants to
report if they had consulted a GP, practice nurse, physio-
therapist, occupational therapist, podiatrist, hospital spe-
cialist, acupuncturist, osteopath or community pharmacist
for their joint pain within the past 12 months using a pre-
viously validated questionnaire [13].
Statistical analysis
Descriptive statistics were used to describe key demo-
graphic data and patient reported outcomes. Data were
analysed for the 16 possible presentations of peripheral
joint pain (including no pain sites as a reference group),
before aggregating these into 5 groups (pain in no sites,
pain in any one site, any two sites, any three sites and
pain in all four sites) for statistical testing. Statistical
tests performed were two-tailed, and p-values of less
than 0.05 were considered statistically significant. The
analysis used 95% confidence interval estimates to
“infer” beyond the study population. Non-response bias
was assessed by aligning patterns of joint pain preva-
lence and survey returns across age and gender
subcategories.
We examined the association between the number of
pain sites with social demographic factors (age, gender,
body mass index (BMI) and deprivation) and health sta-
tus measures including the SF-12, EQ-5D and pain in-
tensity. Pain intensity was measured as a mean score
across painful peripheral joint sites. Comparisons of
Table 1 Age, Deprivation and BMI characteristics stratified by
gender
All
n = 15,083 (%)
Females
n = 8198 (%)
Males
n = 6885 (%)
Age group (years)
45-54 3586 (23.8) 1991 (24.3) 1595 (23.2)
55-64 4561 (30.2) 2401 (29.3) 2160 (31.4)
65-74 4038 (26.8) 2138 (26.1) 1900 (27.6)
75+ 2898 (19.2) 1668 (20.3) 1230 (17.8)
Deprivation scores (IMD)
Most Deprived 2948 (19.6) 1591 (19.4) 1357 (19.7)
Middle 8854 (58.7) 4841 (59.1) 4013 (58.3)
Least Deprived 3276 (21.7) 1765 (21.5) 1511 (22.0)
Body Mass Index (BMI)
Under weight 151 (1.0) 118 (1.5) 33 (0.5)
Healthy weight 5260 (36.8) 3215 (41.6) 2045 (31.1)
Overweight 5750 (40.2) 2697 (34.9) 3053 (46.4)
Obese 3143 (22.0) 1696 (22.0) 1447 (22.0)
BMI classifications devised from NICE (2006) Obesity guidance on the
prevention, identification, assessment and management of overweight and
obesity in adults and children. NICE clinical guideline 43
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consultation behaviour were addressed through descrip-
tive examination and statistical testing of self-reported
consultations between study subgroups. Where odds
were analysed for pain intensity those with mild pain in-
tensity were compared to those with moderate to severe
pain intensity. Mild mean pain intensity was considered
to be a score of 1-5 and moderate to severe pain inten-
sity was a score of 6-10 [14].
Statistical examination of association between number
of pain sites, social demographic and health status mea-
sures were performed through unadjusted (one way
ANOVA) analysis. ANOVA was used to calculate an F-
statistic to determine whether there was a statistically
significant overall difference between the mean scores of
more than two groups and to then check for a linear
trend (via linear contrasts). Multiple linear regression
analysis was carried out to evaluate the association be-
tween number of pain sites and health status measures,
controlling for age, gender, BMI and deprivation. Further
multiple linear regression analysis was carried out to
investigate the independent effects on health status mea-
sures (SF-12, EQ-5D) of, number of pain sites and levels
of pain intensity controlling for age, gender, BMI and
deprivation. Statistical tests using parametric approaches
were generally assumed to be legitimate based on the
large study sample. We used logistic regression to ana-
lyse the association between the number of pain sites
and consultations with general practitioners and practice
nurses. Data were analysed using the Statistical Package
for Social Sciences version 20 (SPSS, Chicago, IL).
Results
Prevalence estimates: Of the 28,443 people who received
the population survey n = 15,083 (53%) returned the
questionnaire, with 11,928 (79%) participants reporting
peripheral joint pain (Fig. 1). Table 1 shows the charac-
teristics of survey responders. Overall, 8206 (54%) of re-
sponders reported multisite peripheral joint pain. Of
those with peripheral joint pain 68% had multisite per-
ipheral joint pain.
Fig. 1 Flowchart of responses to the population survey
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Peripheral joint pain presentations
Peripheral joint pain in the hands, hips, knees or feet
was firstly analysed for 16 possible presentations
(Table 2). Knee pain was the most prevalent single site.
Pain in all four sites was most prevalent. The frequencies
of each presentation of peripheral joint pain identified
the percentage of participants with a combination of
painful joint sites that included the knees 54%, (n =
8159), hands 43%, (n = 6524), feet 40%, (n = 6088) and
hips 39%, (n = 5957). The combinations of peripheral
joint pain in the study population were also descriptively
summarised in terms of their mean (SD) age, BMI, SF-
12 (PCS & MCS) and EQ-5D scores (Table 2).
Using five peripheral joint pain categories trends were
investigated and analysed to compare the mean outcomes
for age, BMI, deprivation, SF-12 (PCS and MCS) and EQ-
5D (Table 3).
Impact on general health and QoL
The independent impact of multisite peripheral joint
pain on SF-12 (PCS and MCS) and EQ-5D scores
(adjusting for age, gender, BMI and deprivation) was
analysed using no sites of joint pain as the reference
category. Unstandardized regression coefficients (b)
demonstrated reduced and therefore poorer SF-12 PCS
scores (−2.68; −5.76; −9.45; −13.89 (p = <0.001)), SF-12
MCS scores (−0.85; −2.21; −3.81; −6.45 (p = <0.001))
and EQ-5D scores (−0.07; −0.14; −0.23; −0.34 (p =
<0.001)), for one, two, three and four sites of peripheral
joint pain respectively. When all variables within the
regression models were standardised to compare indi-
vidual contributions to the SF-12 (PCS and MCS) and
EQ-5D, the variable most significantly associated with
reduced general health and QoL was peripheral joint
pain in four sites.
Table 2 Prevalence of 16 peripheral joint pain presentations and mean age, BMI, the SF-12 PCS and MCS and EQ-5D for all combina-
tions of peripheral joint pain
Prevalence (%) Age
(Mean & SD)
BMI
(Mean & SD)
SF-12 (PCS)
(Mean & SD)
SF-12 (MCS)
(Mean & SD)
EQ-5D
(Mean & SD)
No Pain 20.9 62.6
(11.3)
25.6
(4.0)
51.9
(8.9)
52.5
(8.9)
0.90
(0.15)
Hip pain 4.9 64.0
(11.4)
26.0
(4.2)
47.3
(10.7)
51.2
(9.5)
0.79
(0.21)
Knee pain 9.9 62.5
(11.2)
26.6
(4.3)
48.8
(10.0)
52.5
(8.9)
0.83
(0.17)
Hand pain 5.3 63.7
(10.6)
25.6
(3.9)
50.1
(9.3)
51.3
(9.0)
0.83
(0.19)
Foot pain 4.6 62.4
(11.2)
26.7
(4.11)
49.0
(10.4)
51.2
(9.6)
0.83
(0.19)
Hip & Knee pain 5.6 64.0
(11.0)
27.4
(4.5)
43.3
(11.9)
50.6
(10.5)
0.72
(0.24)
Hip & Hand pain 2.6 65.7
(10.9)
26.3
(4.5)
44.1
(11.8)
50.8
(10.2)
0.74
(0.22)
Hip & Foot pain 2.0 64.4
(10.8)
27.4
(4.7)
44.3
(11.7)
48.7
(10.4)
0.70
(0.25)
Knee & Hand pain 5.7 63.1
(10.9)
26.5
(4.4)
46.0
(11.0)
50.1
(10.1)
0.76
(0.20)
Knee & Foot pain 4.4 62.6
(11.1)
28.1
(4.8)
45.6
(10.8)
50.3
(9.9)
0.74
(0.22)
Hand & Foot pain 3.3 64.2
(11.2)
26.5
(4.2)
45.6
(11.6)
49.4
(10.2)
0.75
(0.20)
Hip, Knee & Hand pain 4.7 65.1
(10.8)
27.1
(4.7)
40.5
(12.1)
49.1
(10.9)
0.65
(0.27)
Hip, Knee & Foot pain 4.4 64.9
(11.6)
28.6
(5.4)
38.6
(12.6)
47.7
(11.3)
0.60
(0.30)
Hip, Hand & Foot pain 2.3 65.4
(11.0)
27.0
(4.8)
42.2
(12.4)
47.6
(10.8)
0.66
(0.27)
Knee, Hand & Foot pain 6.4 64.3
(11.2)
27.8
(5.1)
41.2
(12.1)
48.4
(10.4)
0.66
(0.26)
Hip, Knee, Hand & Foot pain 12.9 66.3
(10.9)
28.4
(5.6)
35.0
(12.2)
45.5
(11.7)
0.51
(0.32)
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Indicators of impact on pain intensity
Table 4 shows mean pain intensity scores stratified by
gender, age, BMI and deprivation. From the summary
data it is clear that mean pain intensity increased signifi-
cantly with each additional peripheral joint pain site.
Statistically significant between groups differences in
pain scores can be seen across all strata of gender, age,
BMI and deprivation (see Table 4).
Using a linear regression model with pain in one site as
the reference category, mean pain intensity increased for
two, three and four sites (0.34; 0.72; 1.4 (p = <0.001) re-
spectively after adjusting for age, gender, BMI and
deprivation. When all variables (age, gender, BMI and
deprivation) within the model were standardised, the vari-
able most significantly associated with increasing mean
pain intensity was peripheral joint pain in four sites.
When analysing the independent effect of number of
pain sites and mean pain intensity on the health status
measures (SF-12 and EQ5D), mean pain intensity had a
greater negative impact than four sites of peripheral joint
pain on the SF-12 PCS (−0.38 compared to −0.23), SF-12
MCS (−0.20 compared to −0.14) and the EQ-5D (−0.44
compared to −0.26). Testing for an interaction effect iden-
tified that there was a compounding effect of both vari-
ables greater than the individual effects for each outcome.
Consultation behaviour
Of the 11,928 who reported peripheral joint pain, 6549
(54.9%) participants reported attending primary care
consultations for their peripheral joint pain over the pre-
vious 12 months. Table 5 describes the distribution of
consultations stratified by the number of sites of periph-
eral joint pain. The proportion (%) of people who chose
to consult increased for every discipline from one to four
sites of joint pain (Table 5).
Odds of consulting a GP or a practice nurse increased
with each additional painful joint site. Using one painful
joint site as a reference category the increase in odds of
consulting a GP with two sites of peripheral joint pain
was 1.66 (1.50, 1.85), three sites 2.52 (2.25, 2.81) and
four sites 4.51 (3.98, 5.11). Similarly the odds for con-
sulting a practice nurse increased with two sites of per-
ipheral joint pain to 1.98 (1.58, 2.49), three sites to 2.40
(1.90, 3.03) and four sites 4.30 (3.41, 5.39).
In those consulting a GP the odds increased to 3.68
(3.37, 4.01) in those with moderate to severe pain inten-
sity. In those consulting a practice nurse odds increased
to 3.81 (3.22, 4.40) for those consulting with moderate
to severe pain intensity. Testing for an interaction effect
between the number of peripheral joint pain sites and
the level of pain intensity demonstrated no statistically
significant interaction effect.
Discussion
This study used a cross-sectional population survey to de-
termine the prevalence and impact of multisite peripheral
joint pain in adults 45 years an older. Multisite peripheral
joint pain was shown to be prevalent and associated with
poorer general health and QoL. Multisite peripheral joint
pain was also shown to have an impact on pain intensity
and consultation behaviour. Negative impact was in-
creased with each additional site of joint pain.
The association between pain and general health was
maintained when stratifying the population sample by
socio-demographic factors (age, gender, BMI, deprivation
score) suggesting increased pain intensity and poorer gen-
eral health are independently associated with peripheral
joint pain, and in particular multisite joint pain. Previous
research investigating multiple joints, often examined bi-
lateral joint problems [4] or moved beyond joint pain to
Table 3 Mean scores for age, BMI, IMD, the SF-12 PCS and MCS and the EQ-5D using the five categories of no joint pain to four sites
of joint pain
No sites of
joint pain
mean (SD)
Pain in one
joint site
mean (SD)
Pain in two
joint sites
mean (SD)
Pain in three
joint sites
mean (SD)
Pain in four
joint sites
mean (SD)
Overall difference
between groups
Linear trend
test
Age 62.6
(11.3)
63.0
(11.1)
63.8
(11.0)
64.8
(11.2)
66.3
(10.9)
F = 43.6a
p < 0.001
F = 171.9b
p < 0.001
BMI 25.6
(4.0)
26.3
(4.1)
27.0
(4.5)
27.7
(5.1)
28.4
(5.6)
F = 138.1a
p < 0.001
F = 531.8b
p < 0.001
IMD 20,685
(8122)
20,985
(8070)
20,324
(8365)
19,657
(8368)
18,561
(8609)
F = 33.2a
P < 0.001
F = 114.6b
P < 0.001
SF-12
(PCS)
51.9
(8.9)
48.8
(10.1)
44.9
(11.5)
40.5
(12.3)
35.0
(12.2)
F = 919.2a
p < 0.001
F = 3637.3b
p < 0.001
SF-12
(MCS)
52.5
(8.9)
51.7
(9.2)
50.1
(10.2)
48.3
(10.8)
45.5
(11.7)
F = 190.9a
p < 0.001
F = 752.6b
p < 0.001
EQ-5D 0.90
(0.15)
0.82
(0.19)
0.74
(0.22)
0.64
(0.27)
0.51
(0.32)
F = 1045.5a
p < 0.001
F = 4151.0b
p < 0.001
a= One-way ANOVA used for interval/ratio data with four degrees of freedom. b = One-way ANOVA with linear contrast with one degree of freedom. IMD sample
range 231-32,468 where lower scores indicate the most deprived areas
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consider multiple anatomical sites, such as the head or the
abdomen etc. [1, 15]. More recent studies have focussed
on a primary joint site, with additional sites as comorbidi-
ties [16, 17].
Symmons and colleagues previously suggested that
multiple sites of joint pain could not be measured by
adding together the estimated number of individuals
with pain in different joint sites, as this would give an in-
flated estimate of the overall burden of musculoskeletal
pain, instead, studies should consider pain in a number
of different sites simultaneously to offer a better estimate
and provide useful insights into patterns of pain [18].
In this study a higher proportion of females responded
to the survey. The results also demonstrated an in-
creased prevalence of multisite peripheral joint pain in
females. This is in keeping with the findings of Peat and
colleagues who stressed that multisite lower extremity
pain was more common in women [4].
A significant association was found between multisite
peripheral joint pain and deprivation scores. A similar
finding was reported by Urwin and colleagues who re-
ported that significant differences in deprivation scores
were found between those who reported musculoskeletal
pain and those that did not [19].
Using a NRS for up to four sites of joint pain to cre-
ate a mean multisite pain intensity score was novel.
There are however more comprehensive measures of
pain suitable for cross-sectional surveys than the NRS,
such as the Brief Pain Inventory [20]; the McGill Pain
Questionnaire [21] or the Chronic Pain Grade [22].
Mallen and colleagues suggest a 3-item prognostic risk
tool that addresses pain interference, pain duration and
pain in multiple sites should be considered for clinical
practice [23]. One potential limitation of this study was
the possibility of recall bias with a 12 month time
period affecting participants’ ability to accurately self-
Table 4 Mean pain score from the selected painful sites, stratified by gender, age, BMI and deprivation
Mean
pain (SD) one site
Mean
pain (SD) two sites
Mean
pain (SD) three sites
Mean
pain (SD) four sites
Overall difference
between groups
Linear trend
test
Gender
Females 3.44 (2.32) 3.91 (2.11) 4.36 (2.12) 5.29 (2.19) F = 191.9a p = <0.001 F = 572.2b
p = <0.001
Males 3.54 (2.30) 3.96 (2.06) 4.45 (2.01) 5.07 (2.15) F = 97.3a p = <0.001 F = 278.0b
p = <0.001
Age group (years)
45-54 3.60 (2.25) 3.88 (2.00) 4.28 (2.08) 4.82 (2.17) F = 30.7a p = <0.001 F = 88.3b
p = <0.001
55-64 3.38 (2.23) 3.76 (1.98) 4.21 (1.98) 4.94 (2.19) F = 76.5a p = <0.001 F = 229.1b
p = <0.001
65-74 3.36 (2.30) 4.01 (2.15) 4.35 (2.02) 5.20 (2.12) F = 93.3a p = <0.001 F = 275.2b
p = <0.001
75+ 3.71 (2.31) 4.20 (2.24) 4.84 (2.23) 5.82 (2.11) F = 82.7a p = <0.001 F = 246.3b
p = <0.001
BMI
Under weight 3.38 (2.30) 4.06 (2.09) 3.88 (2.11) 5.64 (2.19) F = 4.0a p = 0.010 F = 10.2b
P = 0.002
Healthy weight 3.20 (2.26) 3.70 (2.03) 3.91 (2.01) 4.90 (2.18) F = 84.9a p = <0.001 F = 244.6b
p = <0.001
Overweight 3.53 (2.26) 3.82 (2.09) 4.39 (2.01) 5.09 (2.15) F = 96.5a p = <0.001 F = 286.3b
p = <0.001
Obese 4.03 (2.41) 4.37 (2.05) 4.91 (2.07) 5.54 (2.13) F = 69.0a p = <0.001 F = 204.3b
p = <0.001
IMD
Least Deprived 3.34 (2.16) 3.65 (1.98) 3.98 (1.91) 4.53 (1.83) F = 32.1a p = <0.001 F = 94.4b
p = <0.001
Mid Deprived 3.38 (2.29) 3.87 (2.04) 4.30 (2.03) 5.11 (2.18) F = 171.5a
p = <0.001
F = 511.4b
p = <0.001
Most Deprived 4.08 (2.47) 4.48 (2.26) 5.04 (2.21) 5.91 (2.20) F = 65.5a p = <0.001 F = 193.8b
p = <0.001
a= One-way ANOVA used for interval/ratio data with four degrees of freedom. b = One-way ANOVA with linear contrast with one degree of freedom. BMI categor-
ies = underweight = <18.5; Healthy weight = 18.5-24.9; Overweight = 25-29.9; Obese = 30+
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report information about past pain or consultation
behaviour.
We identified an association between peripheral
joint pain and self-reported primary care consulta-
tions. Comparative studies most often report consult-
ation prevalence from medical records, take their
estimates from the general population, and estimate
consultation prevalence for OA rather than peripheral
joint pain [4, 24, 25]. Consultation data gained via self-
report methods, such as this study, may not offer the
precision of medical records for conditions with a
diagnosis, such as OA, but may provide a better esti-
mate of any consultation in which joint pain is men-
tioned opportunistically [26, 27].
Consultations for peripheral joint pain with practice
nurses were identified as being comparatively low with
five times more people with peripheral joint pain con-
sulting their GP than their practice nurse. This suggests
that practice nurses are underutilised in the manage-
ment of musculoskeletal conditions, despite patients
with OA wishing to access practice nurses for the man-
agement of other chronic conditions [28]. However, one
survey in the UK suggested that practice nurses require
specific training and education to gain confidence to
manage musculoskeletal conditions [29].
The findings of this study suggest people consulting
with peripheral joint pain in primary care should be
asked about the number of sites of peripheral joint
pain they have, irrespective of whether or not they
choose only to raise the issue of a primary site. The
high prevalence of multisite peripheral joint pain indi-
cates that a significant number of people presenting
with single site joint pain will have other painful joint
sites. The results suggest that general health and QoL
will be dependent on the number of sites of periph-
eral joint pain. Health Care Professionals should
therefore consider joint pain beyond the primary site
of presentation in order to address what is predomin-
antly a multisite disease.
Conclusion
Peripheral joint pain in multiple sites is highly prevalent
in those 45 years and over and has a significant negative
impact on key dimensions of health. This increasing
public health problem suggests that primary care man-
agement of peripheral joint pain needs to consider joint
pain beyond the primary site of presentation in order to
address the management of OA holistically.
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Table 5 The 12-month period prevalence of consultations with Health Care Professionals for peripheral joint pain, stratified by the
number of joint sites
Consulted Pain in one site
(n = 3722)
Pain in two sites
(n = 3565)
Pain in three sites
(n = 2688)
Pain in four sites
(n = 1953)
Total
(n = 11,928)
General Practitioner 908 (24.3%) 1291(36.2%) 1263 (46.9%) 1215 (62.2%) 4677 (39.2%)
Practice Nurse 125 (3.3%) 247 (6.9%) 232 (8.6%) 284 (14.5%) 888 (7.4%)
Physiotherapist 489 (13.1%) 609 (17.0%) 568 (21.1%) 466 (23.8%) 2132 (17.8%)
Occupational Therapist 61 (1.6%) 73 (2.0%) 73 (2.7%) 82 (4.1%) 298 (2.4%)
Podiatry/Chiropody 243 (6.5%) 408 (11.4%) 434 (16.1%) 421 (21.5%) 1506 (12.6%)
HospitalSpecialist 428 (11.4%) 534 (14.9%) 554 (20.6%) 492(25.1%) 2008 (16.8%)
Acupuncture 75 (2.0%) 106 (2.9%) 91 (3.3%) 102 (5.2%) 374 (3.1%)
Osteopath/Chiropractor 187 (5.0%) 208 (5.8%) 196 (7.2%) 155(7.9%) 746 (6.2%)
Community Pharmacist 194 (5.2%) 259 (7.2%) 254 (9.4%) 265(13.5%) 972 (8.1%)
Columns show the number and proportion of people who have consulted with each discipline from the number of people who reported peripheral joint pain in
one to four sites
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